Skip Navigation

Cardiovascular Research 2005 67(1):21-29; doi:10.1016/j.cardiores.2005.04.012
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by van Empel, V. P.M.
Right arrow Articles by De Windt, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Empel, V. P.M.
Right arrow Articles by De Windt, L. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2005, European Society of Cardiology

Myocyte apoptosis in heart failure

Vanessa P.M. van Empela,b, Anne T.A. Bertranda, Leo Hofstrab, Harry J. Crijnsb, Pieter A. Doevendansa,c and Leon J. De Windta,*

aHubrecht Laboratory and Interuniversity Cardiology Institute Netherlands, Royal Netherlands Academy of Sciences, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands
bDepartment of Cardiology, University Hospital Maastricht, Maastricht, The Netherlands
cDepartment of Cardiology, Heart Lung Center Utrecht, University Medical Center Utrecht, Utrecht, The Netherlands

* Corresponding author. Tel.: +31 30 212 1800; fax: +31 30 251 6464. Email address: dewindt{at}niob.knaw.nl

Human heart failure is preceded by a process termed cardiac remodeling in which heart chambers progressively enlarge and contractile function deteriorates. Programmed cell death (apoptosis) of cardiac muscle cells has been identified as an essential process in the progression to heart failure. The execution of the apoptotic program entails complex interactions between and execution of multiple molecular subprograms. Unlike necrosis, apoptosis is an orderly regulated process and, by inference, a logical therapeutic target if intervention occurs at an early stage. To identify potential therapeutic targets, it is imperative to have a full understanding of the apoptotic pathways that are functional in the cardiac muscle. Accordingly, the present review summarizes the apoptotic pathways operative in cardiac muscle and discusses therapeutic options related to apoptosis for the future treatment of human heart failure.

KEYWORDS Apoptosis; Heart failure; Cell death

Time for primary review 21 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
G. Kewalramani, P. Puthanveetil, F. Wang, M. S. Kim, S. Deppe, A. Abrahani, D. S. Luciani, J. D. Johnson, and B. Rodrigues
AMP-activated protein kinase confers protection against TNF-{alpha}-induced cardiac cell death
Cardiovasc Res, October 1, 2009; 84(1): 42 - 53.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
M. Park, Y.-T. Shen, V. Gaussin, G. R. Heyndrickx, J. Bartunek, R. R. G. Resuello, F. F. Natividad, R. N. Kitsis, D. E. Vatner, and S. F. Vatner
Apoptosis predominates in nonmyocytes in heart failure
Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H785 - H791.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
K. R. McGaffin, B. Zou, C. F. McTiernan, and C. P. O'Donnell
Leptin attenuates cardiac apoptosis after chronic ischaemic injury
Cardiovasc Res, July 15, 2009; 83(2): 313 - 324.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
R. Granata, L. Trovato, M. P. Gallo, S. Destefanis, F. Settanni, F. Scarlatti, A. Brero, R. Ramella, M. Volante, J. Isgaard, et al.
Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart
Cardiovasc Res, July 15, 2009; 83(2): 303 - 312.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
E.-M. Jeong, X. Wang, K. Xu, M. M. Hossain, and J.-P. Jin
Nonmyofilament-associated troponin T fragments induce apoptosis
Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H283 - H292.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
C. C. Chua, J. Gao, Y.-S. Ho, X. Xu, I-C. Kuo, K.-Y. Chua, H. Wang, R. C. Hamdy, J. C. Reed, and B. H.L. Chua
Over-expression of a modified bifunctional apoptosis regulator protects against cardiac injury and doxorubicin-induced cardiotoxicity in transgenic mice
Cardiovasc Res, January 1, 2009; 81(1): 20 - 27.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
E. J. Birks, N. Latif, K. Enesa, T. Folkvang, L. A. Luong, P. Sarathchandra, M. Khan, H. Ovaa, C. M. Terracciano, P. J.R. Barton, et al.
Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy
Cardiovasc Res, August 1, 2008; 79(3): 472 - 480.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
P. A. da Costa Martins and L. J. De Windt
Nix: The Cardiac Styx Between Life and Death
Circulation, January 22, 2008; 117(3): 338 - 340.
[Full Text] [PDF]

Home page
 Circ. Res.Home page
D. Pchejetski, O. Kunduzova, A. Dayon, D. Calise, M.-H. Seguelas, N. Leducq, I. Seif, A. Parini, and O. Cuvillier
Oxidative Stress-Dependent Sphingosine Kinase-1 Inhibition Mediates Monoamine Oxidase A-Associated Cardiac Cell Apoptosis
Circ. Res., January 5, 2007; 100(1): 41 - 49.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
H. M. Piper and E. A. Martinson
Cardiovascular Research speeds up-Even more
Cardiovasc Res, March 1, 2006; 69(4): 773 - 776.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.